Informationen:
Fehler:
ID
13968
Beschreibung
A Clinical Study Testing The Safety and Efficacy of CH5424802/RO5424802 in Patients With ALK Positive Non-Small Cell Lung Cancer; ODM derived from: https://clinicaltrials.gov/show/NCT01588028
Link
https://clinicaltrials.gov/show/NCT01588028
Stichworte
Versionen (1)
- 20.03.16 20.03.16 -
Hochgeladen am
20. März 2016
DOI
Für eine Beantragung loggen Sie sich ein.
Lizenz
Creative Commons BY 4.0
Modell Kommentare :
Hier können Sie das Modell kommentieren. Über die Sprechblasen an den Itemgruppen und Items können Sie diese spezifisch kommentieren.
Itemgroup Kommentare für :
Item Kommentare für :
Um Formulare herunterzuladen müssen Sie angemeldet sein. Bitte loggen Sie sich ein oder registrieren Sie sich kostenlos.
Eligibility ALK-Rearranged Non-Small Cell Lung Cancer NCT01588028
Eligibility ALK-Rearranged Non-Small Cell Lung Cancer NCT01588028
- StudyEvent: Eligibility
Ähnliche Modelle
Eligibility ALK-Rearranged Non-Small Cell Lung Cancer NCT01588028
- StudyEvent: Eligibility
Name
Typ
Description | Question | Decode (Coded Value)
Datentyp
Alias
ecog
Item
performance status: ecog 0-2
boolean
C1520224 (UMLS CUI [1])
NSCLC
Item
non-small cell lung cancer proven by histology
boolean
C0007131 (UMLS CUI [1,1])
C3888914 (UMLS CUI [1,2])
C3888914 (UMLS CUI [1,2])
undefined item
Item
non-small cell lung cancer proven by histology
boolean
C0007131 (UMLS CUI [1,1])
C2974289 (UMLS CUI [1,2])
C0439559 (UMLS CUI [1,3])
C2974289 (UMLS CUI [1,2])
C0439559 (UMLS CUI [1,3])
recist
Item
measurable disease
boolean
C1513041 (UMLS CUI [1,1])
C1709926 (UMLS CUI [1,2])
C1709926 (UMLS CUI [1,2])
renal function
Item
Hepatic function
text
C0221130 (UMLS CUI [1,1])
C0232741 (UMLS CUI [1,2])
C0232804 (UMLS CUI [1,3])
C0232741 (UMLS CUI [1,2])
C0232804 (UMLS CUI [1,3])
Therapy
Item
Therapy
text
C0087111 (UMLS CUI [1,1])
C2974289 (UMLS CUI [1,2])
C2974289 (UMLS CUI [1,2])
Brain metastases
Item
Brain metastases
text
C0220650 (UMLS CUI [1])
History of cardiac disease
Item
History of cardiac disease: congestive heart failure >NYHA class 2. Active CAD (MI more than 6 mo prior to study entry is allowed). Cardiac arrythmias requiring anti-arrythmic therapy (beta blockers or digoxin are permitted) or uncontrolled hypertension
boolean
C0559157 (UMLS CUI [1])
gastrointestinal disorders; abnormalities; study; drug
Item
16. gastrointestinal disorders or abnormalities that would interfere with absorption of the study drug
boolean
C0596599 (UMLS CUI [1])
lactating
Item
pregnancy
boolean
C0032961 (UMLS CUI [1])
C2828358 (UMLS CUI [2])
C2828358 (UMLS CUI [2])